| 30.31 1.25 (4.3%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 36.81 | 1-year : | 39.3 |
| Resists | First : | 31.52 | Second : | 33.65 |
| Pivot price | 29.17  |
|||
| Supports | First : | 28.07 | Second : | 23.36 |
| MAs | MA(5) : | 29.21 |
MA(20) : | 29.84  |
| MA(100) : | 26.05 |
MA(250) : | 22.9 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 52.2 |
D(3) : | 31.7 |
| RSI | RSI(14): 56.1 |
|||
| 52-week | High : | 33.65 | Low : | 17.23 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GMAB ] has closed Bollinger Bands are 46.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 30.46 - 30.58 | 30.58 - 30.72 |
| Low: | 28.97 - 29.09 | 29.09 - 29.23 |
| Close: | 30.07 - 30.28 | 30.28 - 30.51 |
Tue, 11 Nov 2025
Genmab A/S (NASDAQ:GMAB) Q3 2025 Earnings Call Transcript - Insider Monkey
Mon, 10 Nov 2025
Genmab Provides Certain Information Disclosed in Connection - GlobeNewswire
Mon, 10 Nov 2025
Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Mon, 10 Nov 2025
Genmab Announces Proposed Private Offerings - TradingView
Mon, 10 Nov 2025
Genmab Announces Proposed Private Offering of Senior - GlobeNewswire
Mon, 10 Nov 2025
HC Wainwright & Co. Maintains Genmab A (GMAB) Buy Recommendation - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 616 (M) |
| Shares Float | 61 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 10.4 (%) |
| Shares Short | 6,680 (K) |
| Shares Short P.Month | 3,490 (K) |
| EPS | 1.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 86.2 |
| Profit Margin | 37.5 % |
| Operating Margin | 38.9 % |
| Return on Assets (ttm) | 13.2 % |
| Return on Equity (ttm) | 28.1 % |
| Qtrly Rev. Growth | 18.7 % |
| Gross Profit (p.s.) | 5.6 |
| Sales Per Share | 5.92 |
| EBITDA (p.s.) | 2.16 |
| Qtrly Earnings Growth | 73.1 % |
| Operating Cash Flow | 1,130 (M) |
| Levered Free Cash Flow | 771 (M) |
| PE Ratio | 15.7 |
| PEG Ratio | 0 |
| Price to Book value | 0.35 |
| Price to Sales | 5.11 |
| Price to Cash Flow | 16.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|